GO
Loading...

Bristol-Myers Squibb Co

More

  • U.S. stock index futures continued to trade mixed Thursday despite a better-than-expected jobless claims report, as disappointing Apple earnings weighed on technology stocks.

  • Will Tech Earnings Charge Up the Stock Market Rally? Friday, 18 Jan 2013 | 8:33 PM ET
    Google Maps app for Apple ios.

    A flood of earnings reports, including major technology and industrial companies, could make or break the stock market’s surprise January rally in the week ahead.

  • Pipeline Winners: Should You Bank on Biotech? Friday, 11 Jan 2013 | 5:09 PM ET

    Jim Cramer’s researcher Nicole Urken reviews the potential biotech pipeline winners there were highlighted this week on Mad Money.

  • Why Goldman Thinks You Should Dump Bonds Now Friday, 4 Jan 2013 | 2:13 PM ET

    Goldman Sachs strategists have issued a big warning to clients hiding out in bond funds: You're about to lose your shirt.

  • Early Movers: FB, INTC, CAG & More Monday, 31 Dec 2012 | 7:37 AM ET

    Some of the names on the move ahead of the open.

  • What a Weak Yen Does to Corporate Earnings Thursday, 27 Dec 2012 | 3:41 PM ET

    The current weakness in the yen is bad news for U.S. companies competing with Japanese counterparts.

  • Lightning Round: US Steel, Honeywell and More Tuesday, 18 Dec 2012 | 6:37 PM ET

    Cramer makes the call on viewer favorites.

  • Stocks to Watch: P, FB, MFRM & More Wednesday, 5 Dec 2012 | 8:07 AM ET

    Here are Wednesday's morning movers.

  • After-Hours Buzz: P, MFRM & More Tuesday, 4 Dec 2012 | 4:41 PM ET

    Check out which companies are making headlines after the bell Tuesday:

  • Ryan: Dividend Tax Hikes Make Drug Stocks Sick? Tuesday, 20 Nov 2012 | 1:51 PM ET

    Three of the top ten dividend stocks in the S&P are drug stocks. Will they lose out if dividend taxes rise?

  • Your First Move for Tuesday November 20th Monday, 19 Nov 2012 | 6:13 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • *DOJ, SEC convinced enforcement changing corporate culture. At least eight of the world's top 10 drugmakers, including Bristol-Myers Squibb Co, Pfizer Inc and Johnson&, have disclosed U.S. probes under the 1977 Foreign Corrupt Practices Act.

  • Pfizer 3Q report to focus on pipeline, new drugs Friday, 26 Oct 2012 | 8:07 AM ET

    TRENTON, N.J.-- Pfizer Inc., the world's biggest drugmaker by revenue, will focus on progress on key experimental drugs, recent drug approvals and its ongoing corporate makeover when it reports third-quarter results before the stock market opens Tuesday.

  • WASHINGTON, Oct 25- Boehringer Ingelheim Pharmaceuticals Inc agreed to pay $95 million to U.S. government agencies to settle civil allegations that it illegally marketed drugs for unapproved uses, the U.S. Justice Department said on T hur sday.

  • *Q3 sales fall 19 pct to $6.68 bln vs consensus $6.75 bln. *Core EPS $1.51 vs consensus $1.44; full-year outlook held. LONDON, Oct 25- AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot.

  • *Q3 sales fall 19 pct to $6.68 bln vs consensus $6.75 bln. Core EPS $1.51 vs consensus $1.44; full-year outlook held. LONDON, Oct 25- AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot.

  • *Q3 sales fall 19 pct to $6.68 bln vs consensus $6.75 bln. Core EPS $1.51 vs consensus $1.44; full-year outlook held. LONDON, Oct 25- AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot.

  • AG: 5 drug companies to pay $18.6M to La. Thursday, 25 Oct 2012 | 12:25 AM ET

    BATON ROUGE, La.-- Louisiana Attorney General James "Buddy" Caldwell's office says five pharmaceutical companies will pay the state more than $18.6 million to resolve allegations they misreported drug price information to the state's Medicaid program.

  • *Dow down 0.2 pct, S&P 500 off 0.3 pct, Nasdaq off 0.3 pct. *Boeing dips after results, but Dow Chemical jumps on job-cut plans. The S&P 500 has lost 3.6 percent over the past five sessions, hurt by weak earnings outlooks and top-line revenue misses from large multinational companies.

  • Oct 24- Eli Lilly and Co and Bristol-Myers Squibb Co posted lower-than-expected profit as their former top medicines were pounded by cheaper generics and sales of other products disappointed, sending their shares lower. Lilly earned $1.33 billion, or $1.18 per share, in the third quarter. That compared with $1.24 billion or $1.11 per share a year earlier.